Share
573 Posts.
lightbulb Created with Sketch. 138
clock Created with Sketch. 14/03/25
21:41
Share
Originally posted by Motors:
↑
As Garner delightfully outlines in his piece today, PVL will essentially charge PER a fee for it to buy and sell bio-tech stocks PVL chooses, under the guise of a management fee. PER will instantly trade below NTA as it values the fee load. AND PVL isn't even good at this sort of thing itself, it trades below NTA as well , hahaha. By all means happy for someone else to try and find a good use for the $18 mill while PER trades below cash backing , but this is insulting , fees on fees on fees with PVL the only potential winner , and especially given current management looks very good to me.
Expand
I'd be curious to know how many Gennadi and Co still hold.
(20min delay)